Inmate Central Inmate Central, where civil and family-friendly discourse about off-audio topics (other than religion and politics) is welcome. |
|
Nuvaxovid, is a protein based Covid vaccine developed in the US by Novavax and said to be 90% effective, including against the omicron variant.
"Unlike the novel mRNA vaccines produced by Pfizer/BioNTech and Moderna or viral vector made by AstraZeneca and Johnson & Johnson, Nuvaxovid is a protein subunit vaccine. It contains a non-infectious component on the surface of the Sars-CoV-2 virus, which induces a protective immune response when the body's immune cells come into contact with it."
This post is made possible by the generous support of people like you and our sponsors:
Topic - An alternative to mRNA vaccines - Postal Grunt 11:13:27 02/21/22 (1)
- If it provides better protection against infection it may prove superior...- - srdavis2000 12:21:02 02/21/22 (0)